| ADE | Antibody-Dependent Enhancement |
| ADCP | Antibody-Dependent Cellular Phagocytosis |
| ADCC | Antibody-Dependent Cellular Cytotoxicity |
| AMCD | Antibody-Mediated Complement Deposition |
| bNAbs | Broadly Neutralising Antibodies |
| CDC | Complement Dependent Cytotoxicity |
| CMV | Cytomegalovirus |
| DENV | Dengue Virus |
| ELISA | Enzyme-Linked Immunosorbent Assay |
| Fab | Fragment Antigen Binding |
| Fc | Fragment Crystallisable |
| FcR | Fragment Crystallisable Receptor |
| HCV | Hepatitis C Virus |
| HA | Hemagglutinin |
| HIV | Human Immunodeficiency Virus |
| HPV | Human Papilloma Virus |
| IAV | Influenza A Virus |
| ITAM | Immunoreceptor Tyrosine-Based Activation Motif |
| LCMV | Lymphocytic Choriomeningitis Virus |
| MAC | Membrane Attack Complex |
| MARV | Marburg virus |
| mAb | Monoclonal Antibody |
| MHC | Major Histocompatibility Complex |
| Nab | Neutralising Antibody |
| NK cell | Natural Killer Cell |
| nNAb | Non-neutralising Antibody |
| pIgR | Poly Ig Receptor |
| RBD | Receptor Binding Domain |
| ScFv | Single Chain Variable Fragment |